Cutoff Point Separating Affected and Unaffected Familial Hypercholesterolemic Patients Validated by LDL-receptor Gene Mutants
Hiroshi Mabuchi, 明広 稲津, Shoji Katsuda(Red Cross Hospital), Atsushi Nohara(Kanazawa University), Wen Xin Yu(Kanazawa University), Tsuyoshi Nozue(Yokohama Sakae Kyosai Hospital), Toshinori Higashikata(Kanazawa University), Yoshihiro Noji(Fukui Prefectural Hospital), Junji Koizumi, 宏 馬渕, Akihiro Inazu, Hong Lu, 淳 野原, 剛照 川尻, Junji Kobayashi, Masa‐aki Kawashiri(Kanazawa University)
Cited by 0
Related Papers
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
|Journal of Atherosclerosis and Thrombosis|2018|226
Guidelines for the Management of Familial Hypercholesterolemia
|Journal of Atherosclerosis and Thrombosis|2012|177
Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia
|European Heart Journal|2017|165
Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis
|Clinical Chemistry and Laboratory Medicine (CCLM)|2001|151
Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease
|Journal of Atherosclerosis and Thrombosis|2018|138